BIBI , N., & MALIK , M. (2025). COMPARISON OF 550MG/DAY VERSES 1100 MG/DAY RIFAXIMIN IN SECONDARY PREVENTION OF BOTH COVERT AND OVERT HEPATIC ENCEPHALOPATHY. Pakistan Journal of Intensive Care Medicine, 5(01), 71. https://doi.org/10.54112/pjicm.v5i01.71